Skip to content

Use of an evidence based checklist in follow up care of epilepsy patients and its effect on quality of life.

Comparing outcomes of epilepsy patient follow-up care with and without a checklist – A randomised control trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/072796
Enrollment
108
Registered
2024-08-20
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G409- Epilepsy, unspecified

Interventions

Intervention1: Evidence based checklist: A tool used in wholesome care of epilepsy patient follow up. It will be used at the time of registering patient into trial. It will be used once only at the ti

Sponsors

Dr Vaibhav Bhandari
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a. People with epilepsy more than or equal to 18 years coming to neurology OPD, AIIMS, Delhi b. Follow up more than 1 year in AIIMS OPD, all subtypes of epilepsy and seizure as defined by ILAE c. Provide consent

Exclusion criteria

Exclusion criteria: a. Less than 18 years of age b. Refusal to consent c. Newly diagnosed epilepsy

Design outcomes

Primary

MeasureTime frame
assessment of change in quality of life by QOLIE-31 scale.Timepoint: Assessment will be done at baseline, before using checklist and after 1 year of follow up. QOLIE 31 after 1 year will be compared from baseline as well as from control arm.

Secondary

MeasureTime frame
Assessment of change in seizure frequency from baseline as well as comparison from control arm after using checklist. • Assessment of change in seizure severity by National Hospital Seizure Severity Score (NHS3) from baseline as well as comparison from control arm after using checklist. • Assessment of early identification & treatment of adverse drug reaction by subscale score of QOLIE-31 • Assessment of early identification of cognitive function by subscale score of QOLIE-31.Timepoint: all points mentioned above will be checked at baseline & after 1 year of follow up.

Countries

India

Contacts

Public ContactDr Mamta Bhushan Singh

All India Institute of Medical Sciences, New Delhi

mbsneuro@gmail.com8929042755

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026